Welcome to the all-new Vetlearn

  • Exciting News Coming to Vetlearn in August 2014!
    Coming soon you'll be able to access...
  • Nearly 5,000 Compendium and Veterinary
  • Thousands of industry Conference Proceedings
  • All-new articles (CE and other topics) for the
    entire healthcare team
  • Over 500 hours of interactive CE Videos
  • An engaging new community for asking
    questions, making connections and more!

To access Vetlearn, you must first sign in or register.


  • Registration for new subscribers will open in August 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Compendium September 2008 (Vol 30, No 9)

Veterinary Therapeutics Selected Abstract: Pharmacokinetics of Buprenorphine Following Intravenous and Oral Transmucosal Administration in Dogs

by Sara M. Cowan, DVM, Susan E. Bunch, DVM, PhD, DACVIM

    Abbo LA, Ko JCH, Maxwell LK, et al. Vet Ther 2008;9(2):83-93.

    Pharmacokinetic analysis of buprenorphine administered to six healthy dogs via the oral transmucosal (OTM) route at doses of 20 and 120 µg/kg was conducted using liquid chromatography"electrospray ionization"tandem mass spectroscopy (LC-ESI-MS/MS). Bioavailability was 38% ± 12% for the 20 µg/kg dose and 47% ± 16% for the 120 µg/kg dose. Maximum plasma concentrations were similar for buprenorphine doses of 20 µg/kg IV and 120 µg/kg OTM. Sedation and salivation were common side effects, but no bradycardia, apnea, or cardiorespiratory depressive effects were seen. When the two OTM dosing rates were normalized to dose, LC-ESI-MS/MS analysis of buprenorphine and its metabolites detected no significant difference (P > .05), indicating dose proportionality. The results of this study suggest that OTM buprenorphine may be an alternative for pain management in dogs.

    Click here to read the complete article from the Summer 2008 issue of Veterinary Therapeutics.

    This study was funded by the Purdue University School of Veterinary Medicine. Buprenorphine and metabolite determinations were partially funded by NIH grant RO1-DA10100.

    NEXT: Abstract Thoughts — Chronic Carpal Sprains in Doberman Pinschers


    Did you know... Because chemotherapeutic agents consistently suppress hematopoiesis, their administration should be monitored with periodic complete blood counts.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More